⌘K
Loading ticker…
IN8bio, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, IN8bio, Inc. Common Stock (INAB) has a 3-month relative strength percentile of 28 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 41. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 0.93×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
28 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
INAB is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -11.1% / -24.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INAB Jan avg: -5.69% median: -3.20% win: 0% σ: 7.18% n: 4 2022-04-12 → 2026-05-29 | INAB Feb avg: -14.12% median: -14.16% win: 25% σ: 15.75% n: 4 2022-04-12 → 2026-05-29 | INAB Mar avg: -14.99% median: -13.99% win: 25% σ: 18.27% n: 4 2022-04-12 → 2026-05-29 | INAB Apr avg: -8.08% median: -0.68% win: 40% σ: 20.23% n: 5 2022-04-12 → 2026-05-29 | INAB May avg: 26.38% median: 16.67% win: 60% σ: 48.64% n: 5 2022-04-12 → 2026-05-29 | INAB Jun avg: -32.23% median: -39.10% win: 25% σ: 25.33% n: 4 2022-04-12 → 2026-05-29 (current) | INAB Jul avg: -2.46% median: 0.57% win: 50% σ: 15.05% n: 4 2022-04-12 → 2026-05-29 | INAB Aug avg: -10.66% median: -4.52% win: 50% σ: 18.96% n: 4 2022-04-12 → 2026-05-29 | INAB Sep avg: -18.37% median: -11.91% win: 0% σ: 22.44% n: 4 2022-04-12 → 2026-05-29 | INAB Oct avg: -3.90% median: -4.62% win: 25% σ: 5.82% n: 4 2022-04-12 → 2026-05-29 | INAB Nov avg: -3.95% median: -4.61% win: 50% σ: 11.05% n: 4 2022-04-12 → 2026-05-29 | INAB Dec avg: 25.40% median: 25.47% win: 75% σ: 33.94% n: 4 2022-04-12 → 2026-05-29 |